Literature DB >> 15996083

Refractory polyarteritis nodosa successfully treated with infliximab.

Jamal Al-Bishri1, Nicole le Riche, Janet E Pope.   

Abstract

We describe a woman with severe polyarteritis nodosa (PAN) with visceral involvement unresponsive to multiple immunosuppressive drugs. Infliximab treatment was very effective in this case. Infliximab may potentially be used as an alternative agent for the treatment of patients with PAN refractory to conventional therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996083

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Infliximab for the treatment of refractory polyarteritis nodosa.

Authors:  Shira Ginsberg; Itzhak Rosner; Gleb Slobodin; Michael Rozenbaum; Lisa Kaly; Nizar Jiries; Nina Boulman; Abid Awisat; Haya Hussein; Irina Novofastovski; Amal Silawy; Doron Rimar
Journal:  Clin Rheumatol       Date:  2019-04-10       Impact factor: 2.980

2.  Tumor necrosis factor blockade in the management of children with orphan diseases.

Authors:  Riva Brik; Vardit Gepstein; Eli Shahar; Dorit Goldsher; Drora Berkovitz
Journal:  Clin Rheumatol       Date:  2007-01-12       Impact factor: 2.980

Review 3.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

4.  Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?

Authors:  Aurélie Saunier; Nahéma Issa; Marie-Anne Vandenhende; Philippe Morlat; Marie-Sylvie Doutre; Fabrice Bonnet
Journal:  RMD Open       Date:  2017-06-29

5.  Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report.

Authors:  Chrong-Reen Wang; Chao-Chun Yang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.

Authors:  Jeong-Seon Lee; Joong-Gon Kim; Soyoung Lee
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

7.  Therapy for vasculitic neuropathies.

Authors:  Kenneth C Gorson
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

Review 8.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

9.  Anti-cytokine targeted therapies for ANCA-associated vasculitis.

Authors:  Malgorzata M Bala; Teresa J Malecka-Massalska; Magdalena Koperny; Joanna F Zajac; Jarosław D Jarczewski; Wojciech Szczeklik
Journal:  Cochrane Database Syst Rev       Date:  2020-09-29

10.  The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.

Authors:  Satoko Matsuo; Keigo Hayashi; Eisaku Morimoto; Ayako Kato; Ken-Ei Sada; Haruki Watanabe; Mariko Takano-Narazaki; Katsue Sunahori-Watanabe; Tomoko Kawabata; Jun Wada
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.